Box Inc (NYSE: BOX) shares are trading higher in Tuesday's after-hours session after the company reported better-than-expected results and issued strong second-quarter guidan
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), announced today that the abstract for the first-in-human Phase 1 dose escalation study of SYS6002 (CRB-701) has been released, and the